Complications Archives

October 11, 2024

Increased Fatigue May Predict CLL Disease Progression

Based on outcomes reported by patients, increased fatigue may predict disease progression in relapsed CLL / SLL patients on ibrutinib or zanubrutinib.

September 23, 2024

Bone Health in Chronic Lymphocytic Leukemia

Chronic lymphocytic leukemia (CLL) patients with abnormal bone health are at high risk for fragility fractures, which can occur with minimal trauma.

June 20, 2024

Immunoglobulin Replacement Therapy for Patients with CLL

Immunoglobulin replacement therapy reduces infection risk in patients with CLL, but more work is needed to ensure patients get their IgG levels tested.

September 5, 2023

Merkel Cell Carcinoma, Margaritaville, and CLL

Patients diagnosed with blood cancers are at higher risk of developing second cancers, especially second blood cancers.

July 14, 2023

Development of Second Cancers Among Patients with Blood Cancers Including CLL / SLL (Chronic Lymphocytic Leukemia)

Patients diagnosed with blood cancers are at higher risk of developing second cancers, especially second blood cancers.

February 15, 2023

Karen Jones on Warm Autoimmune Hemolytic Anemia and wAIHA Warriors

In this interview, Dr. Brian Koffman spoke with Karen Jones, executive director of wAIHA Warriors, a nonprofit dedicated to helping patients with warm autoimmune hemolytic anemia (wAIHA). They discussed wAIHA Warriors and how wAIHA is connected to chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).

February 15, 2023

ASH 2022: Dr. Irina Murakhovskaya on Warm Autoimmune Hemolytic Anemia (wAIHA) in Patients with Chronic Lymphocytic Leukemia (CLL)

Warm autoimmune hemolytic anemia is a common and serious complication of chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). The ENERGY study will test the efficacy of nipocalimab for treating warm autoimmune hemolytic anemia.

January 13, 2023

Dr. Shahzad Mustafa on What it Means to be Immunocompromised for Those with CLL / SLL

\In this interview, Dr. Brian Koffman spoke with Dr. Shahzad Mustafa, Division Chief of Allergy, Immunology, and Rheumatology at Rochester Regional Health and Clinical Associate Professor of Medicine at the University of Rochester School of Medicine and Dentistry. They discussed immune deficiency (a.k.a. being immunocompromised) and what that means

August 25, 2022

ASCO 2022: Incidence, Predictors, and Outcomes of Cardiovascular Events in Patients with Chronic Lymphocytic Leukemia

CLL patients are at higher risk for several types of cardiac events and have higher rates of in-hospital mortality, regardless of why they were admitted. In addition, this trial was seriously flawed as it did not address what CLL treatments were used. We know certain therapies such as BTKi,

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Complications

Increased Fatigue May Predict CLL Disease Progression

Bone Health in Chronic Lymphocytic Leukemia

Immunoglobulin Replacement Therapy for Patients with CLL

Merkel Cell Carcinoma, Margaritaville, and CLL

Development of Second Cancers Among Patients with Blood Cancers Including CLL / SLL (Chronic Lymphocytic Leukemia)

Karen Jones on Warm Autoimmune Hemolytic Anemia and wAIHA Warriors

ASH 2022: Dr. Irina Murakhovskaya on Warm Autoimmune Hemolytic Anemia (wAIHA) in Patients with Chronic Lymphocytic Leukemia (CLL)

Dr. Shahzad Mustafa on What it Means to be Immunocompromised for Those with CLL / SLL

ASCO 2022: Incidence, Predictors, and Outcomes of Cardiovascular Events in Patients with Chronic Lymphocytic Leukemia

CLL SOCIETY FAST FIND

QUICK LINKS

ABOUT CLL SOCIETY

CONTACT